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By
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M.S., Nutrition, University of New Mexico, 2020
Abstract
Prevalence of Type 2 Diabetes (T2DM) in New Mexico (NM) has steadily increased
to 12.5% in 2019.1 Registered Dietitian Nutritionists (RDNs) play a critical role in the T2DM
healthcare team. A web-based survey was distributed to NM clinicians [Medical Doctors
(MD), Doctors of Osteopathic Medicine (DO), Certified Nurse Practitioners (CNP), and
Certified Physician Assistants (PA-C)] investigating barriers preventing referral of patients
with T2DM to an RDN.
In total, 132 clinicians completed the survey (average age=52 years; 54.5% CNPs,
32.6% MDs, 9.1% PA-Cs, 3.9% DOs; 44% female). Most (67.4%) did not have an RDN
employed in their practice. The majority (72.7%) of participants were aware of the referral
process to an RDN, however, 51.5% referred <10% of patients with T2DM to an RDN. Lack
of access to an RDN was the most common barrier to referral (50.8%). Findings suggest
clinicians recognize the importance of RDNs in T2DM management, but lack of access to an
RDN is a barrier in NM.
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Operational Definitions
Hemoglobin A1C (A1C): Glycated hemoglobin is a measure of glucose attached to
hemoglobin. This blood test measures the average blood glucose level over a three-month
period.
Body Mass Index (BMI): A person’s weight in kilograms divided by the square of height in
meters.
Obese: Body mass index of >30kg/m2.
Overweight: Body mass index of 25-29.9kg/m2.
Cardiovascular Disease (CVD): A group of disorders affecting the heart and blood vessels.
Prediabetes: Fasting blood glucose level of 100-125 mL/dL.
Diabetes Mellitus (DM): Metabolic condition of high blood glucose levels.
Type 1 Diabetes Mellitus (T1DM): Auto-immune response in which the immune system
destroys insulin-producing β-cells of the pancreas requiring insulin.
Type 2 Diabetes Mellitus (T2DM): Progressive loss of adequate β-cell insulin secretion or
insulin resistance.
Medical Nutrition Therapy (MNT): Provided by a registered dietitian nutritionist, which is
a specific application of the nutrition care process (nutrition assessment, diagnosis, and
monitoring/evaluation).
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Chapter 1:
BACKGROUND AND INTRODUCTION
I.

Defining Diabetes
One in every ten people (34.2 million) in the United States (U.S.) has diabetes

mellitus (DM).2 Of those, one in five people in the U.S. do not know they have diabetes.2 An
additional one in three (88 million) adults in the U.S. has prediabetes.2 Diabetes is diagnosed
when blood glucose levels are above normal blood glucose range (>126 mg/dL fasting,
>200mg/dL two hours after a 75 gram oral glucose tolerance test, or >6.5% hemoglobin
A1C).3 When carbohydrate-containing foods are consumed, they are broken down into
glucose, which is then taken up by cells facilitated by the hormone insulin.4 There are two
main types of diabetes, type 1 (T1DM) and type 2 (T2DM).4 T1DM is an autoimmune
disease that destroys the β-cells in the pancreas that make the hormone insulin, therefore,
subcutaneous insulin must be administered daily.4 T1DM is most often diagnosed in
childhood and during adolescence.
T2DM develops when the pancreas does not produce enough insulin, or when cells
resist the action of insulin.4 T2DM is most commonly diagnosed in adults, although the
prevalence of T2DM among the pediatric population increased 4.8% in the United States
from 2002 to 2015.5 The diagnosis of T2DM among children and adolescents was rarely
observed until the mid-1990s.6-7 The increased prevalence of T2DM is associated with an
increased prevalence of obesity.6-7
T2DM is multifactorial in etiology, however, overweight and obesity are primary
contributing factors. Overweight and obesity are generally defined by body mass index
(BMI), which is calculated as a ratio of weight (kg) to height (m) squared.8 Clinicians use
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BMI as a screening tool to estimate an individual’s health risk and identify candidates for
weight loss. BMI is categorized into four weight categories: underweight (BMI <18.5kg/m2),
normal weight (BMI 18.5-24.9kg/m2), overweight (BMI 25.0-29.9kg/m2), and obese (BMI
>30kg/m2). Obesity is further classified into obesity class I (BMI > 30.0-34.9kg/m2), obesity
class II (BMI >35.0-39.9 kg/m2), and obesity class III (BMI >40.0 kg/m2).8 An increased risk
of all-cause mortality is associated with obesity compared to normal-weight individuals.9
T2DM manifests with numerous signs and symptoms including increased thirst,
frequent urination, increased hunger, unintended weight loss, fatigue, blurred vision, frequent
infections, darkened skin areas, and poor wound healing.10 Without proper medical and
dietary management, T2DM leads to numerous complications including cardiovascular
disease (CVD), kidney disease, blindness, amputations, and premature death.10
II.

Prevalence of Obesity and Diabetes in New Mexico
The prevalence of obesity and T2DM are increasing at an alarming rate in New

Mexico (NM). From 1990 to 2018, obesity prevalence in adults in NM increased from 8.1%
to 32.2%.11 In 2018, NM ranked 22nd among 51 states within the U.S. for the prevalence of
obesity. The prevalence of T2DM is much greater in overweight and obese adults in NM
(11.2% and 20.1%, respectively) compared to individuals classified within the normal BMI
range (6.7%).11
In 2018, NM ranked 11th among the 51 states in the U.S. for the prevalence of adult
DM;11 12.5% of NM adults have DM, higher than the U.S. prevalence of 10.5%.11 Adults 65
years of age and older have the highest prevalence of T2DM (23.7%) compared to the 45-64year-old age group (16.4%) and the 18-44-year-old age group (4.3%).11 Lower household
income is associated with T2DM in NM.12 A prevalence of T2DM of 18.1% was observed in
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NM adults earning <$15,000/year versus 7% in NM adults who earned >$75,000/year.12
Education and employment status in NM are associated with T2DM diagnosis.12 Individuals
with a higher level of education are less likely to be diagnosed with T2DM as well as
individuals who are employed. 12
In 2017, DM ranked sixth among the leading causes of mortality in NM, accounting
for 673 deaths.13 In 2017, 220,000 NM adults had diagnosed DM and 549,000 NM adults had
diagnosed prediabetes.13 Each year, approximately 12,000 individuals in NM are diagnosed
with DM.13 Additionally, approximately 59,000 adults in NM do not know they have T2DM
and 39.7% of adults in NM have a diagnosis of prediabetes.13
III.

Economic Impact of Diabetes
Adults with DM have increased healthcare expenses compared to adults without DM.

Individuals with DM have approximately 2.3 times greater health care expenditures
compared to individuals without DM.14
Adults with DM have increased ambulatory, emergency visits, and inpatient days
compared to individuals without DM.15 Higher healthcare costs for DM are also associated
with increased medications and clinician visits for DM-associated complications.
From 2012 to 2017, DM expenses increased by 26% ($82 billion), due to the growth of
T2DM diagnoses.15 In 2017, medical costs in NM associated with adult prediabetes,
undiagnosed DM, and diagnosed DM was $1.905 billion.15 The 2017 total annual direct and
indirect costs for DM (prediabetes, diagnosed DM, undiagnosed DM, gestational DM) in NM
was $2.45 billion.16 The U.S. spent $327 billion in 2017 on DM associated costs (direct and
indirect costs).16
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IV.

Reducing Diabetes Complications
Weight loss plays a significant role in controlling blood glucose levels and reducing

the risk of CVD in adults with T2DM.17 In patients classified as overweight and obese,
modest weight loss (5-10%) can largely improve DM management. One study found that
86% of individuals with T2DM who were overweight or obese exhibited poorer glycemic
control, higher blood pressure, and higher lipid levels compared to individuals with a normal
BMI.17 Obesity and weight management interventions greatly impact and promote DM
management while improving overall health and decreasing healthcare costs.17
V.

Diabetes Prevention
Diet and lifestyle factors contribute to the risk of developing T2DM.18 Hu et al found

90% of T2DM cases could be prevented by diet and lifestyle factors.19 Lifestyle factors that
may reduce the risk of T2DM include maintaining a BMI <25kg/m2, eating a diet high in
fiber and polyunsaturated fats and low in saturated/trans fats and glycemic load, moderate
alcohol intake, regular exercise, and abstaining from smoking.19 Obesity is the greatest risk
factor for developing T2DM.17
Diet and exercise are paramount to weight loss and T2DM prevention. Research
suggests common lifestyle modifications resulting in weight loss can successfully reduce the
risk of T2DM.18
VI.

Referring Patients with Type 2 Diabetes to a Registered Dietitian Nutritionist
Registered Dietitian Nutritionists (RDNs) are defined as food and nutrition experts.20

RDNs are required to meet numerous academic requirements including completing a
bachelor’s degree from an accredited university with course work approved by the
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Accreditation Council for Education in Nutrition and Dietetics (ACEND), completion of a
minimum of 1200-hours of supervised practice, completing and passing the RDN exam, and
completing 75 continuing education credits every five years to maintain the RDN
credential.20 RDNs play a vital role in providing Medical Nutrition Therapy (MNT) for DM
disease prevention and management. Numerous studies have demonstrated the effectiveness
of MNT in treating T2DM;22,23,24,25 however, clinicians may not always refer T2DM patients
to an RDN.
There are many reasons why clinicians may not routinely refer patients diagnosed
with T2DM to an RDN for MNT. Potential reasons may include insurance reimbursement
issues, lack of awareness of RDN services, lack of interest by the patient, and lack of access
to an RDN. RDNs’ knowledge, expertise, and guidance are an integral component of T2DM
self-management.
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Chapter 2:
REVIEW OF RELATED LITERATURE
I.

Studies Assessing the Integration of an RDN for Diabetes Treatment
Integrating RDNs into the health care team is a vital component of DM

management.21 Historically, primary care physicians may provide minimal nutrition
education to patients with T2DM. Physicians may not provide adequate nutrition education
due to lack of time, limited nutrition knowledge, or reimbursement issues. Nutrition
education to promote proper carbohydrate counting, maintain glycemic control, and promote
healthy eating patterns to aid weight loss if necessary is important for reducing the risk of
T2DM complications.
The purpose of this literature review is to examine the role of RDNs in the
collaborative practice of DM care; the effectiveness of RDNs in T2DM prevention,
treatment, and management; and to identify barriers clinicians experience in referring
patients with T2DM to RDNs. The findings of published studies and the need for further
research will be discussed.
Marincic et al 22 conducted a study in 2017 to develop methodology for tracking
patient outcomes after RDN interventions, document outcomes for patients with T2DM
attending American Diabetes Association-recognized programs, and obtain outcome data to
support reimbursement and public policy initiatives to improve patient access to diabetes
self-management education/support (DSME) and MNT. Eight-eight adults 29-81 years of age
(n=52 females, n=36 males) participated in the study. Anthropometric and biochemical
measurements (body weight, BMI, A1C levels) were documented at baseline before DSME
and MNT. The intervention consisted of one individual assessment and three 2.5-hour group
classes that were provided for approximately four months. Following group classes, patients
6

were instructed to maintain a two-week food diary and record blood glucose levels. After two
to three months, participants met with an RDN for a one-hour MNT visit. Hemoglobin A1C
decreased significantly in participants who received DSME and MNT from baseline
(8.74%+2.30%) to the end of the program (6.82+1.37%; P<0.001). A significant reduction of
hemoglobin A1C was also observed one year after the program completion compared to
baseline (6.90+1.16%; P<0.001). At the end of the program, 72% of participants met the
hemoglobin A1C target of <7.0%, compared to 27% of participants at baseline (P=0.0008).
This study provides evidence of the importance and effectiveness of RDNs on
multidisciplinary healthcare teams to treat patients with T2DM.
Grohmann et al 23 explored 23 adult patients’ perspectives when incorporating a DM
educator [Registered Nurse (RN) and an RDN] into the primary care setting to treat and
manage DM. Primary care providers referred newly diagnosed patients with T2DM (age
range 40-50 years; n=15 females, n=8 males) to the DM education team, which was
integrated into the primary care practice. Patients in the DM treatment program met with an
RN and RDN for 30 minutes each. If time was limited, the patient met with the RN and RDN
at the same time. The RN and RDN assessed the subjects’ overall DM knowledge, self-care,
and lifestyle habits. After the assessment, an individualized treatment plan was developed
with the patient and shared with the physician. Subjects continued to meet with the DM
educators for one year to review, discuss, and revise the patient’s treatment plan.
Patient interviews were conducted one-year post-intervention. Subjects reported a
greater sense of respect, support, awareness, knowledge, and confidence in managing their
diabetes when DM educators were incorporated into their diabetes care. Subjects reported
that they were more likely to self-manage their DM with the help of the DM team. The
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integration of DM education into primary care facilities reduced barriers of self-management
education, developed person-centered care environments, increased patient satisfaction, and
supported physicians’ care. The integration of DM education within a primary care setting
was found to provide greater access and improve patients’ overall health outcomes.
Pozniak et al 24 surveyed 300 clinicians to investigate perceptions of the adequacy of
reimbursement for DM care. The average age of the participants was 46 years, 200 were
primary care providers and 100 were endocrinologists, and the majority were male (75%).
The study found that 32% of participants were unable to provide DM education due to time
constraints or lack of reimbursement. Physicians reported that if reimbursement for DM care
was higher, they would be able to incorporate a multidisciplinary DM care team into the
practice. This study revealed that physicians are not offering DM nutrition therapy due to low
reimbursement.
Alameddine et al 25 examined the impact of nutritional counseling in patients with
T2DM in Lebanon. Adult subjects (n=333; n=184 males, n=149 females) were recruited
from two main medical outpatient centers. Inclusion criteria included a diagnosis of T2DM
for at least one year. Subjects completed a questionnaire including five sections: sociodemographic characteristics, disease attributes, patients’ perceptions regarding T2DM
management, the practice of lifestyle modifications, and referral to an RDN by a physician.
The study found that physicians referred 34% of participants to an RDN and 91% of all
participants that were referred to an RDN met with an RDN. The study revealed the
influential impact physician referral has in promoting nutrition therapy in patients with
T2DM. However, the research also identified that patients are six times more likely to see an
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RDN if they have insurance coverage. This study highlights the importance of clinician
referral and MNT insurance coverage for optimal DM healthcare.
Huang et al 26 evaluated the effect of RDN–led management of DM on glycemic
control and macronutrient intake in 154 adults with T2DM within primary care clinics in
Taiwan and examined the association between macronutrient intake and glycemic measures.
Subjects were randomly assigned to a routine care control group (n=79) or an RDN-led
intervention group (n=75). The intervention group received on-site DM education every three
months for one year. Significant improvements in fasting blood glucose levels were observed
in the intervention group with patients who had poorly controlled baseline A1C (>7%)
resulting in a reduction of 13.4mg/dL compared to the control group whose fasting blood
glucose level increased 16.9mg/dL after one year (p=0.007).
II.

Summary of Previous Research
A review of the literature indicates a gap in research on clinician referral of patients

with T2DM to RDNs for MNT. Published research has not assessed the barriers that prevent
clinicians from referring patients with T2DM to an RDN for MNT.
III.

Study Objective and Hypothesis
The objective of this study was to assess the barriers that preclude clinicians in NM

from referring patients with T2DM to an RDN for MNT.
Hypothesis: The greatest barrier that precludes clinicians in NM from referring patients with
T2DM to an RDN for MNT is the lack of access to an RDN.
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Chapter 3:
METHODOLOGY
I.

IRB Approval
The Institutional Review Board (IRB) protocol application was submitted to the

University of New Mexico Human Research Protections Office (HRPO) in September 2019.
IRB approval was granted in December 2019. Recruitment of participants was initiated after
IRB approval in March 2020.
II.

Research Design
This cross-sectional research study utilized a qualitative and quantitative survey. The

survey consisted of multiple-choice and open-ended questions. The study’s objectives were
to identify barriers that prevent clinicians in NM from referring patients with T2DM to an
RDN, as well as to explore the relationship between demographic characteristics including
geographic location of clinician practice and referral barriers and referral percentages.
Independent variables included professional credentials, gender, age, length of time in
practice, location of practice, and employment type. The dependent variables were the
percent of patients referred to RDNs on average, frequency of discussing weight loss and
nutrition with patients with T2DM, and the barriers that prevent the referral of patients with
T2DM to an RDN.
III.

Participants
The participant population included currently licensed New Mexico clinicians with

the credentials Medical Doctor (MD), Doctor of Osteopathic Medicine (DO), Certified Nurse
Practitioner (CNP), or Physician Assistant (PA-C) who treat adult patients with T2DM. Other
inclusion criteria included currently working full-time, part-time, or PRN; currently treating
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patients with T2DM; internet access and email address; and ability to comprehend English.
Exclusion criteria included inability to comprehend English, no internet access, and not
currently working with patients with T2DM or retired.
IV.

Sampling & Recruitment
Email addresses of potential participants were obtained from the New Mexico

Medical Board, New Mexico Nurse Practitioner Council, and New Mexico Board of
Osteopathic Medicine for clinicians in New Mexico. From the potential participant lists, the
clinician contact information was sorted based on currently active clinicians practicing in
New Mexico. After screening, 5,434 active clinicians were deemed eligible to participate in
the research study and received the recruitment email.
A recruitment email with study information and a link to the survey was sent to the
5,434 individuals on March 9, 2020, requesting research participation. Invitees had one
month (four weeks) from the time the initial email was sent to complete the survey. The
initial contact email included a consent form with consent elements and the research survey
link. A waiver of consent documentation (no signature) was approved for this study by the
UNM IRB; participants indicated consent by starting the survey.
Reminder emails were sent out weekly during the four-week time frame. During the
four weeks, four invitees emailed the student investigator expressing their inability to
complete the survey due to the current COVID-19 pandemic. Unfortunately, postponing
research was not feasible and the decision was made to continue with the research. Other
invitees expressed their inability to complete the survey as they were currently not practicing
in NM or had retired.
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V.

Data Collection

Survey Development
The student investigator developed the survey, with input from the research team. A
pilot survey was emailed to three clinicians (one MD, one PA-C, and one CNP) with an
additional questionnaire to assess survey clarity and obtain feedback. Slight changes were
made to the pilot survey after pilot survey participants’ comments were taken into
consideration.
The online research survey was developed using Opinio software, UNM’s survey
platform. The student investigator was trained by the UNM Information Technologies (UNM
IT) Opinio staff to develop and administer the survey. Participants did not receive
compensation for participating.
The first two questions of the research survey were used as screening questions to
assess eligibility to participate. The survey consisted of a total of twelve questions including
multiple choice and short response questions and took approximately 5-10 minutes to
complete. Survey questions obtained information about participants’ demographics,
percentage of patients with T2DM that were referred to an RDN, and barriers that prevented
referral of patients with T2DM to an RDN. Participants completed the survey via the internet
at their location of choice.
Data Storage
All electronic data collected were de-identified and were coded with an ID number
assigned in Opinio. Data were downloaded from Opinio into an excel spreadsheet and stored
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on the principal investigator and student investigator’s password-protected computers until
the completion of data analysis.
I.

Data Analysis
For the statistical analysis of data, Excel and Statistical Analysis Software (SAS) 9.4

were used by the research team. Missing and/or incomplete data were removed prior to data
analysis. Demographic data including professional credentials, age, gender, and practice
location were reported using descriptive statistics including mean and standard deviation for
continuous variables and percent and frequency for categorical variables. Participant age was
divided into four categories for data analysis: 25-35, 36-45, 46-55, and >55 years old.
Qualitative responses were downloaded for tabulation and data analysis. Fisher’s tests were
conducted to examine differences in outcome variables by professional credentials, age,
gender, and place of employment.
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Chapter 4:
RESULTS
I.

Response Rate
Of the 5,434 clinicians that were sent the recruitment email, 207 participants

responded to the survey (response rate of 3.8%). Of the 207 participants who responded, 132
(63.8%) participants met inclusion criteria and completed all survey questions.
Many clinicians who did not participate in the survey emailed the student investigator
with a reason for not participating. The most common reasons for not participating were
retirement (n=35), not seeing patients with diabetes (n=19), and not practicing in NM (n=15).
Sixteen participants emailed the researcher asking to be removed from future invitations,
stating no reason. Two emails were received stating the clinician was deceased. Four
clinicians noted that they could not participate due to the COVID-19 pandemic.
II.

Survey Data

Participant Demographics
The participant population included 132 licensed NM clinicians who treated adult
patients with T2DM: 72 Certified Nurse Practitioners (54.5%), 43 Medical Doctors (32.6%),
12 Physician Assistants (9.1%), and 5 Doctors of Osteopathic Medicine (3.9%).
The majority of participants were female (n=91; 68.9%), 28.8% were male (n=38),
1.5% (n=2) did not list their gender, and 0.8% (n=1) chose “gender not listed.” Average age
of participants was 52 years with a standard deviation of 11.2 years. The majority of
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participants (n=55; 42.3%) were over the age of 55. Thirty-eight (29.2%) were within the 46
to 55 years old category, 24 (18.5%) were within the 36-45 years old category, and
13 (10.0%) were within the 25-35 years old category.
The majority of participants had more than 10 years of experience (n=56; 43.1%).
Forty-one (31.5%) participants had five to ten years of experience and 33 (25.4%) had
practiced less than five years.
The majority of participants practiced in Albuquerque (n=58; 44.6%). Forty-two
(32.3%) participants practiced in other locations in NM. Of those, ten (7.7%) practiced in Las
Cruces, nine (6.9%) in Santa Fe, six (4.6%) in Rio Rancho, and five (3.9%) in Roswell.
The most common place of employment was in a community clinic (n=40; 30.3%).
Private practice (n=38; 28.8%), other (n=27; 20.5%), and hospital (n=25; 18.9%) settings
were closely distributed. The fewest (n=2; 1.5%) participants were employed at long-term
care/nursing facilities. Table 1 summarizes participant characteristics.
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Table 1. Participant Demographics (n=132)
Characteristics
Credentials
Certified Nurse Practitioner
Medical Doctor
Certified Physician Assistant
Doctor of Osteopathic Medicine
Gender
Female
Male
Gender not listed/not reported
Age (mean=52+11.2 years)
25-35
36-45
46-55
>55
Time Practiced (mean=11.4+9.7)
<5 years
5-10 years
>10 years
Location of Practice in NM
Albuquerque
Las Cruces
Santa Fe
Rio Rancho
Roswell
Other location in NM
Place of Employment
Community Clinic
Private Practice
Hospital
Other

III.

n

%

72
43
12
5

54.55
32.58
9.09
3.79

91
38
3

68.94
28.79
2.27

13
24
38
55

10.00
18.46
29.23
42.31

33
41
56

25.38
31.54
43.08

58
10
9
6
5
42

44.62
7.69
6.92
4.62
3.85
32.31

40
38
25
29

30.30
28.79
18.94
21.97

Discussion of Diet and Weight Management
Frequency of clinician discussion of diet and nutrition habits with patients with

T2DM was assessed. The majority of participants (n=89; 67.4%) discussed diet and nutrition
habits with patients with T2DM every visit, 40 (30.3%) discussed diet and nutrition habits
every other visit, and three (2.3%) rarely discussed diet and nutrition habits. Frequency of
clinician discussion of weight loss with patients diagnosed with T2DM and overweight or
obesity was also evaluated. Sixty-six (50.0%) of participants reported always discussing
weight-loss, 59 (44.7%) of participants discussed weight loss every-other-visit, 6 (4.6%) of
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participants rarely discussed weight-loss, and 1 (0.8%) reported never discussing weight-loss
with patients diagnosed with T2DM.
IV.

Participant Referral Percentage
More than half (n=67; 51.5%) of all participants reported that they referred less than

10% of their patients with T2DM to an RDN on a monthly basis. The majority of survey
respondents (n=96; 72.7%) reported that they knew the process of referring a patient
diagnosed with T2DM to an RDN; however, 27.3% did not know the referral process. Most
participants did not have an RDN employed in their practice (n=89; 67.4%). The majority of
private practice (n=35; 92.1%) or community clinic clinicians (n=30; 75%) did not have an
RDN employed in their practice.
V.

Factors Affecting Referral of Patients with T2DM to an RDN
Of the 132 participants, the top three barriers experienced by clinicians in referring

patients diagnosed with T2DM to an RDN were lack of access to an RDN (n=66; 50.8%),
patient not interested in seeing an RDN (n=54; 41.5%), and lack of patient transportation
(n=46; 35.4%). Few clinicians reported being unaware of RDN services (n=11; 8.5%),
unsure of the benefit of an RDN for patients (n=8; 6.2%), or unsure of the usefulness of diet
advice for their patients (n=2; 1.5%).
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Table 2. Perceived Barriers Preventing Referral to a Registered Dietitian Nutritionist
(RDN) (n=132)
Factors that prevent referral of T2DM patient to an RDN
Lack of access to RDN
Patient not interested in seeing RDN
Patient lack of transportation to RDN
Other
Uninsured/ability to afford RDN
Patient not interested in changing diet
Clinician provides nutrition education
Clinician unaware Medical Nutrition Therapy for patients w/T2DM is covered by most
insurances
Clinician unaware of RDN services
Clinician unsure of RDN benefit for patients
Clinician unsure of the usefulness of diet advice for patients

VI.

n
66
54
46
38
31
31
27
25

%
50.77
41.54
35.38
29.23
23.85
23.85
20.77
19.23

11
8
2

8.46
6.15
1.54

Differences between Participant Subgroups

Clinician Type
Responses to the survey questions were compared by clinician type (MD, DO, PA-C,
CNP). The results are presented in Table 3. There were no significant differences by clinician
type in the frequency of discussing diet and nutrition habits with patients with T2DM,
however, a higher percentage of DOs (n=4; 80%) reported always discussing diet and
nutrition habits compared to MDs (n=25; 58%), PA-Cs (n=6; 50%), and CNPs (n=54; 75%).
There were no significant differences in the frequency of discussing weight loss with patients
diagnosed with overweight or obesity and T2DM by clinician type; however, more DOs were
found to discuss weight loss at every visit compared to MDs, CNPs, and PA-Cs.
No significant difference was found in the percentage of patients with T2DM referred
to an RDN on a monthly basis by clinician type.
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Table 3. Responses to Survey Questions by Clinician Type (n=132)

Frequency of discussing diet and nutrition habits
Always (every visit)
Sometimes (every other visit)
Rarely
Frequency of discussing weight loss
Always; every visit with overweight/obese patient
with T2DM
Sometimes; every other visit with overweight/obese
patient with T2DM
Rarely
Never
Frequency of referral of patients with T2DM to an
RDN
<10%
10-25%
26-50%
>50%
Knowledge of the referral process to an RDN
Yes
No

MD (n=43)

DO (n=5)

CNP (n=72)

PA (n=12)

n
25
16
2

%
58.14
37.21
4.65

n
4
1
0

%
80.00
20.00
0.00

n
54
17
1

%
75.00
23.61
1.39

n
6
6
0

%
50.00
50.00
0.00

18

41.86

3

60.00

42

58.33

3

25.00

21

48.84

2

40.00

27

37.50

9

75.00

4
0

9.30
0.00

0
0

0.00
0.00

2
1

2.78
1.39

0
0

0.00
0.00

pvalue
0.2574

0.2013

0.471
25
8
3
5

60.98
19.51
7.32
12.20

1
2
2
0

20.00
40.00
40.00
0.00

36
17
7
12

50.00
23.61
9.72
16.67

5
3
2
2

41.67
25.00
16.67
16.67

32
11

74.42
25.58

4
1

80.00
20.00

51
21

70.83
29.17

9
3

75.00
25.00

0.9826

Gender
Responses to the survey questions were compared by clinician gender. There were no
significant differences in the frequency of discussing diet and nutrition and weight loss with
patients with T2DM, the percent of patients with T2DM referred to RDNs, or the knowledge
of the referral process to an RDN by gender.
Age Group
There were no significant differences in the frequency of discussing diet and nutrition
and weight loss with patients with T2DM, the percent of patients with T2DM referred to
RDNs, or the knowledge of the referral process to an RDN by age group.
Employment Type
Responses to survey questions by employment type (hospital, private practice,
community clinic, or other) are presented in Table 4. There was a statistically significant
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difference (p=0.0008) between clinician’s employment type and frequency of discussing diet
and nutrition with patients with T2DM. The majority of clinicians at community clinics
(n=33; 82.5%), in private practice (n=28; 73.7%), and other locations (n=19; 70.4%) reported
discussing diet and nutrition habits always (every visit) compared to nine (36.0%) hospital
clinicians. The majority of hospital clinicians reported sometimes or rarely (n=16; 64%)
discussing diet and nutrition habits with patients with T2DM.
Frequency of discussing weight loss with patients with T2DM was also significantly
different by type of employment (p=0.003). The majority of clinicians discussed weight loss
every visit with a patient diagnosed with overweight/obesity and T2DM in community clinics
(n=24; 60%), private practice (n=22; 57.9%), and other locations (n=14; 51.9%) while the
majority of clinicians working in hospitals sometimes or rarely discussed weight loss
(n=19; 76%).
A statistically significant difference was observed between the clinician’s
employment type and whether an RDN is employed within the clinician’s practice
(p=0.0001). Thirteen (52%) of clinicians working in a hospital reported having an RDN at
their location while most clinicians working in other locations did not report having an RDN
available; 92.1% of private practices, 75.0% of community clinics, and 52.9% of other
locations did not have an RDN available at their location.
Geographic Location
There was no statistically significant difference in the percentage of patients with
T2DM referred to an RDN on a monthly basis or knowledge of the referral process to an
RDN by practice geographic location.
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Table 4. Responses to Survey Questions by Type of Employment (n=132)
Hospital
(n=25)
n
%
Frequency of
discussing diet
and nutrition
habits
Always (every
visit)
Sometimes
(every other
visit)
Rarely
Frequency of
discussing
weight loss
Always; every
visit with
overweight/obe
se patient
w/T2D
Sometimes;
every other
visit with
overweight/obe
se patient
w/T2D
Rarely
Never
Frequency of
referral of
patients with
T2DM to an
RDN
<10%
10-25%
26-50%
>50%
Knowledge of
the referral
process to an
RDN
Yes
No

Private Practice
(n=38)
n
%

Community clinic
(n=40)
N
%

Other
(n=29)
n
%

0.0017
9

36.00

28

73.68

33

82.50

19

65.52

14

56.00

10

26.32

6

15.00

10

34.48

2

8.00

0

0.00

1

2.50

0

0.00
0.0165

6

24.00

22

57.89

24

60.00

14

48.28

15

60.00

16

42.11

15

37.50

13

44.83

4
0

16.00
0.00

0
0

0.00
0.00

1
0

2.50
0.00

1
1

3.45
3.45

13
4
3
4

54.17
16.67
12.50
16.67

21
9
2
6

55.26
23.68
5.26
15.79

23
8
6
2

58.97
20.51
15.38
5.13

10
9
3
7

34.48
31.03
10.34
24.14

0.323

0.2798
18

72.00

25

65.79

28

70.00

25

86.21

7

28.00

13

34.21

12

30.00

4

13.79
<0.000
1

Has RDN
Yes
No
I don’t know

p-value

13
10
2

52.00
40.00
8.00

3
35
0

7.89
92.11
0.00

9
30
1

21

22.50
75.00
2.50

13
14
2

44.83
48.28
6.90

Perceived Barriers by Clinician Type
There were no significant differences in the perception of barriers to referring patients
with T2DM to an RDN by clinician type (Table 5). DOs, however, were more likely to
perceive that patients were not interested in changing diet (60%) compared to MDs (16.3%),
CNPs (28.2%), and PA-Cs (9.1%), which approached significance (p-value=0.0761).
Table 5. Perceived Barriers by Clinician Type

Lack of access to RDN
Unaware MNT for patients w/T2DM is
covered by most insurances
Patient not interested in seeing RDN
Clinician provides nutrition education
Patient not interested in changing diet
Clinician unsure of RDN benefit for
patients
Unaware of RDN services
Clinician unsure of the usefulness of diet
advice for patients
Uninsured/ability to afford RDN
Pt lack of transportation to RDN

MD (n=43)
n
%
19 44.19
5
11.63

DO (n=5)
n
%
2
40
0
0

CNP (n=72)
n
%
39 54.93
19 26.76

PA (n=12)
n %
6 54.55
1 9.09

p-value

18
11
7
3

41.86
25.58
16.28
6.98

4
1
3
1

80
20
60
20

28
13
20
4

39.44
18.31
28.17
5.63

4
2
1
0

36.36
18.18
9.09
0

0.3894
0.8317
0.0761
0.4973

3
0

6.98
0

0
0

0
0

8
2

11.27
2.82

0
0

0
0

0.7196
0.6359

8
12

18.6
27.91

1
2

20
40

20
28

28.17
39.44

2
4

18.18
36.36

0.6859
0.6401

0.6922
0.143

Perceived Barriers by Facility Type
Barriers to referral of patients with T2DM to RDNs were examined by facility type
(Table 6). Significantly more clinicians practicing in community clinics (62.5%), private
practices (62.2%), and hospitals (41.7%) reported lack of access to an RDN as a barrier when
referring patients with T2DM to an RDN when compared to other (27.6%) (p=0.0108).
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Table 6. Perceived Barriers by Employment Facility Type

Lack of access
to RDN
Unaware MNT
for pt.’s with
T2DM is
covered by
most
insurances
Patient not
interested in
seeing RDN
Clinician
provides
nutrition
education
Patient not
interested in
changing diet
Clinician
unsure of RDN
benefit for
patients
Unaware of
RDN services
Clinician
unsure of the
usefulness of
diet advice for
patients
Uninsured/
ability to
afford RDN
Patient lack of
transportation
to RDN

VII.

Hospital (n=25)
N
%

Private Practice (n=38)
n
%

Community clinic (n=40)
N
%

Other (n=29)
n
%

p-value

10

41.7

23

62.2

25

62.5

8

27.6

0.0108

7

29.2

5

13.5

10

25.0

3

10.3

0.2064

11

45.8

13

35.1

15

37.5

15

51.7

0.5040

4

16.7

8

21.6

9

22.5

6

20.7

0.9805

5

20.8

7

18.9

12

30.0

7

24.1

0.7171

1

4.2

1

2.7

5

12.5

1

3.5

0.3386

3

12.5

2

5.41

4

10.0

2

6.9

0.7988

0

0

1

2.7

1

2.5

0

0

1.000

3

12.5

11

29.7

14

35.0

3

10.3

0.0445

9

37.5

11

29.7

20

50.0

6

22.3

0.0737

Qualitative Response Data

Participants had the option to specify what other factors prevented referral of patients
with T2DM to an RDN. Many respondents commented that lack of available RDNs to refer
to (n=13) and insurance reimbursement (n=6) were barriers. One respondent commented,
“There are not enough, we need more in the community to be able to refer patients to them.”
Another participant commented, “Lack of Spanish speaking RDNs. Prior challenging
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experiences: RDNs who lacked appropriate cultural and language skills for the population
that I have worked with: Spanish speaking, limited education, homeless, and financial
barriers also an issue.” While many participants commented, “availability,” other participants
commented, “I don’t know of anyone to refer my patients to. The health plans don’t have
programs with CDEs anymore and there are only a few endocrinologists, which don’t
advertise any options for outside patients in their practices. I refer to endocrinologist
sometimes for diet education.” One participant stated, “office hours for RDN conflict with
their work schedules.” Another participant commented, “I have worked for eight years in Los
Alamos and there was no RDN available in Los Alamos until ~2018. Next closest RDN for
8+ years was through Pres-Espanola Hospital. Tremendous need for RDN in this area.”
Participants also commented on insurance coverage: “Even those with insurance are
unwilling to pay copays of $50 per week to see a dietitian regularly,” while other participants
commented “copay,” and another participant commented, “I would disagree that it is easy to
have insurance cover a registered dietitian.” Participants’ comments support the need for
greater access to RDNs and also the need for full insurance coverage for patients with T2DM
to meet with an RDN.
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Chapter 5:
DISCUSSION
The objective of this study was to conduct a cross-sectional survey of practicing
clinicians in New Mexico to assess barriers that prevent clinician referral of patients with
T2DM to an RDN. The secondary objective was to examine the referral barriers and referral
frequency by participant demographic variables, and geographic location of participants
including professional credentials, gender, age, length of time in practice, location of
practice, and employment type.
I.

Interpretation of Results
In the entire sample, two of the top three most common barriers [lack of access to an

RDN (50.8%) and lack of patient transportation (35.4%)] experienced by clinicians in
referring patients with T2DM may be attributed to the majority of NM being rural-urban.27
Lack of access to an RDN is consistent with the low number of RDNs employed in NM.28 In
addition, 10 (41.7%) of the clinicians reported a lack of access to an RDN when working in a
hospital setting. Typically, hospitals are known to employ RDNs, yet, 40% of clinicians
employed in a hospital setting stated that they do not have an RDN employed in their
hospital. The lack of an RDN employed in a hospital setting in NM may be due to the lack of
total RDNs available in NM or the rural location or small size of a hospital, which may not
generally employ an RDN.
Based on this study, a small percentage (n=11; 8.5%) of clinicians stated lack of
awareness of an RDN as a barrier, indicating that the majority of NM clinicians are aware of
RDN services for patients with T2DM. Few clinicians (n=8; 6.2%) indicated that they were
unsure of the benefit of an RDN for patients or that they were unsure of the usefulness of diet
advice for their patients (n=2; 1.5%). Research has demonstrated the effective role MNT has
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in improving outcomes for patients with T2DM.29 For example, Mottalib et al 29 evaluated
patients with T2DM whom had consulted with an RDN. The study randomized 108
overweight or obese patients with T2DM into three groups: group one met with an RDN to
develop an individualized eating plan, group two met with an RDN and followed a structured
meal plan, and group three met with an RDN and followed a structured meal plan and also
received weekly phone support from an RDN. The study was conducted for a total of 16
weeks consisting of three, one-hour visits with an RDN and two 15-minute telephone followup calls (at 4 and 12 weeks). After 16 weeks, groups two and three had significant reductions
of HbA1C, body weight, body fat percentage, and waist circumference.
Al-Shookri et al.30 reported that MNT significantly improved HbA1C, fasting plasma
glucose, and weight in patients with T2DM. The study consisted of adult subjects (30-70
years of age), who had been diagnosed with T2DM, but free of any T2DM complications.
Participants (n=170) were randomly assigned to a group receiving usual nutritional care
(n=85) or an intervention group (n=85). Usual care included a one-hour appointment with an
RDN discussing general principles of nutrition management and the referring physician
determined whether a follow-up visit is necessary. The intervention group received practice
guidelines nutritional care, consisting of three appointments with an RDN (one meeting for
the first three months) and an ongoing follow-up visit every six to twelve months. The RDN
made necessary assessments and nutritional interventions during the visits.
Results demonstrated that participants who received nutritional care based on practice
guidelines had significant improvements in HbA1C (-0.8%, p=0.0001) and fasting plasma
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glucose (-1.3mmol/L, p=0.003) compared to the usual nutritional care group. Significant
improvements were also found in the practice guidelines group compared to the usual
nutritional care group in waist circumference (96.9± 7.9 vs. 100.0 ± 8.7 cm, p=0.019),
triglycerides (1.42 ± 0.58 vs. 1.98 ± 0.96 mmol/L, p=0.001), cholesterol levels (5.1 ± 1.0 vs.
5.5 ± 0.9mmol/l, p=0.009) and LDL cholesterol levels (3.58 ± 0.98 vs. 3.89 ±
0.98mmol/l, p=0.046). Study results support the impact that MNT has in treating patients
with T2DM. Patients with T2DM receiving MNT have greater long-term glucose control and
higher quality overall health.
Wynn et al.31 studied the role physicians play in the management of patients with nutritionrelated conditions and the frequency of nutrition counseling implementation. A total of 451
physicians in Canada were surveyed to assess perceived barriers to nutrition counseling.
More than half of all physicians (58.1%) stated that more than 60% of their patients would
benefit from nutritional counseling. The majority of participants reported making fewer than
10 referrals (36.9%). Significantly more rural physicians (41.7%) referred patients to an
RDN compared to urban physicians (21.7%, p=<0.0005). The study identified the need for
integration of RDNs into primary care settings to promote T2DM management.
Study Strengths
This study included a well-rounded distribution of clinicians from cities and towns in
New Mexico. The majority of participants practiced in Albuquerque, the largest city in New
Mexico, although other cities and rural towns were represented. Participants also represented
a wide age range (26-74 years), indicating that study results may be generalized to a wide age
range of clinicians. In this study, more females responded to the survey compared to males,
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consistent with other studies indicating females are more likely to respond or participate in
research than men.32
II.

Limitations
There were several limitations to this study. A substantial limitation was the

COVID-19 pandemic. Clinicians expressed that the pandemic limited their ability to respond
to the survey, impacting the response rate and sample size. Study results may have been
influenced by the low response rate. The response rate may have been higher if the survey
had been conducted prior to the COVID-19 pandemic and if the survey had been sent only to
clinicians who treat patients with diabetes.
III.

Implications
Results from this study indicate that the lack of RDNs within clinicians’ geographic

practice location is the greatest barrier for clinician referral of patients with T2DM to an
RDN. More research is needed to assess alternative MNT delivery methods to increase
access to an RDN, including telehealth services. Further collaborative involvement of RDNs
into primary care settings may increase referral of patients with T2DM to an RDN.
Recruitment of RDNs to practice in NM and increasing the number of dietetic internship
positions in NM may also improve clinicians’ perceived access to RDNs. If RDNs complete
internships in NM, they may be more likely to work in NM after internship, which will
increase the number of RDNs working in NM. The recruitment of Spanish speaking RDNs to
work in underserved areas of NM is also essential to overcome barriers. The second most
frequently reported barrier by clinicians in this study was the lack of interest by patients with
T2DM to meet with an RDN highlighting the need to educate or minimize misconceptions of

28

the role of an RDN to patients with T2DM and assess why patients are uninterested in
meeting with an RDN.
IV.

Future Research
Future research is needed to further assess solutions for overcoming the three greatest

barriers (lack of access, patient not interested in seeing an RDN, and patient lacks
transportation to an RDN) that prevent clinicians in NM from referring patients with T2DM
to RDNs. The impact of an on-site RDN on clinicians’ referral rate and barriers to referral
may be a next step, in addition to the effectiveness of telehealth-based RDN services as
telehealth may be more cost effective compared to hiring an on-site RDN.
Recently, a growing interest in nutrition education has been seen within medical
schools across the country. The increase of nutrition knowledge and awareness among
clinicians could have a significant impact on referring patients with T2DM to an RDN.
Further research is needed to determine if the frequency of referral is greater among
clinicians who have received some nutritional education during their health professional
education.
Nearly one in five (19.2%) participants were unaware that many insurance companies
and plans cover MNT for T2DM. RDNs may consider increasing clinician and patient
awareness regarding insurance coverage. Some clinicians reported that they were unaware of
RDN services or were unsure of the benefit of an RDN for patients. RDNs may consider
continuing to educate clinicians on the role of the RDN within the healthcare team and the
importance of nutrition education and MNT in improving patient outcomes.
Future research should include patients with T2DM to determine patient perceptions
of clinician referral to an RDN. Additionally, patient assumptions regarding the role of the
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RDN in T2DM should be explored. It is vital to obtain the opinions of patients with T2DM to
accurately identify solutions to decrease barriers that exist for patients. Some clinicians
indicated in this survey, for example, “my patient is not interested in changing their diet.”
Examining patients’ opinions will help determine if clinicians accurately understand their
patients’ perspectives on RDNs.
V.

Conclusions
This study suggests that clinicians in NM are aware of the benefits of RDNs in

managing patients with T2DM, but many barriers prevent NM clinicians from referring
patients with T2DM to an RDN for MNT. The three greatest barriers observed were lack of
access to RDNs, patient not interested in seeing an RDN, and patient lacks transportation to
an RDN. Innovative methods such as telehealth services may improve access to an RDN and
transportation barriers, which may increase the percentage of patients with T2DM that are
referred to an RDN. Previous studies illustrate the positive impact RDNs have on the overall
health, blood glucose management, and reduction of complications in patients with T2DM,
which are associated with decreased health care costs. The multidisciplinary approach of
including an RDN in the treatment and management of patients with T2DM may improve the
overall health of patients with T2DM in NM.
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Appendices
Appendix A: Survey
Survey to Assess How New Mexico Clinicians Refer Patients with Type 2 Diabetes to a
Registered Dietitian Nutritionist
What are your credentials?
Medical Doctor (MD)
Doctor of Osteopathic Medicine (DO)
Certified Nurse Practitioner (CNP)
Physician Assistant (PA-C)
Are you involved in the primary care of patients with Type 2 Diabetes?
Yes
No
If answered “yes” to the above question, you are eligible to participate in the survey.
If answered “no” to the above question, you are not eligible to participate in the survey. Your
time is greatly appreciated.
1. What is your gender?
Female
Male
Prefer not to say
Not listed
2. What is your age (years)?________________
3. How long have you practiced (full or part-time) as a primary care provider in New
Mexico (years)? ____________________
4. In which city/town in New Mexico do you currently
practice?_______________________________________
5. Where are you employed?
Hospital
Private practice
Community clinic
Long-term care/nursing facility
Other (please specify) ____________________
6. Approximately, what is the average percentage of your patients whom you have seen
in the last month who are diagnosed with Type 2 Diabetes? ___________________
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7. How often do you discuss diet and nutrition habits with patients with Type 2
Diabetes?
Always (every visit)
Sometimes (every other visit)
Rarely
Never
Only if the patient asks
8. How often do you discuss weight loss with an overweight or obese patient with Type 2
Diabetes?
Always; every visit with overweight/obese patient w/T2D
Sometimes; every other visit with overweight/obese patient w/T2D
Rarely
Never
Only if the patient asks
9. Do you know the process involved with referring a patient with Type 2 Diabetes to a
Registered Dietitian Nutritionist (RDN)?
Yes
No
10. Is there a Registered Dietitian Nutritionist (RDN) employed in your practice?
Yes
No
I don’t know
11. Please estimate the percentage of your patients, on a monthly basis, with Type 2
Diabetes that you refer to a Registered Dietitian Nutritionist (RDN)?
____________________
12. What factors prevent you from referring patients with Type 2 Diabetes to a
Registered Dietitian Nutritionist (RDN)? Please check all that apply
Lack of access to an RDN within geographic location
I didn’t know that Medical Nutrition Therapy for patients with Type 2 Diabetes is covered
by most insurance
My patients are not interested in seeing an RDN
I provide nutrition education to my patients
My patients are not interested in changing their diet
I do not know how useful an RDN is to my patients
I am unaware of the services an RDN can provide for my patients
I am not sure the usefulness of diet advice for my patients
Many of my patients are uninsured & cannot afford to see an RDN
Many of my patients lack of transportation to an RDN
Other (please specify)____________________________
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13. What would help you refer patients with Type 2 Diabetes to a Registered Dietitian
Nutritionist (RDN)?
___________________________________________________________________________
Thank you for your time to complete this survey!
If you have any questions or concerns, please contact:
Rebecca Lamoreux, RDN
email: rlamoreux@unm.edu
Phone: (505)699-2615
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Appendix B: Email Invitation
Subject Line: Opportunity to Participate in Research
Dear Participant,
I am conducting a research study about Referring Patients with Type 2 Diabetes to a
Registered Dietitian Nutrition in New Mexico.
You are receiving this email because you are a practicing clinician in New Mexico.
The purpose of this research study is to improve the referral rate among patients with Type 2
Diabetes to a Registered Dietitian Nutritionist in New Mexico.
If you agree to participate, this study will involve completing the following electronic survey.
The potential risks may include loss of confidentiality and privacy.
There is no direct benefit to those who participate in the study. The study will, however,
generate knowledge to help improve communication between clinicians and Registered
Dietitian Nutritionists (RDNs) in New Mexico. The long-term goal is to help develop the
necessary instruments to increase referral rate of patients with Type 2 Diabetes to a Registered
Dietitian Nutritionist (RDN).
You do not have to be in this study, your decision to be in any study is totally voluntary.
If you feel you understand the study and would like to participate, please click “OK” to
participate.
If you have questions prior to participating, please contact:
• Rebecca Lamoreux
• Email: rlamoreux@unm.edu
• Phone: 505-699-2615
Thank you for your time,
Rebecca Lamoreux, RDN

Rebecca Lamoreux, RDN
Student Investigator
Principal Investigator: Dr. Deborah Cohen, DCN, RD
Study Title: Referring Patients with Type 2 Diabetes to a Registered Dietitian Nutritionist in
New Mexico
IRB # : 1433018-1
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